Compositions of pd-1 antagonists and methods of use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) C07K 14/705 (2006.01)

Patent

CA 2734908

Methods of treating cancer and infectious diseases utilizing a treatment regimen comprising administering a compound that reduces inhibitory signal transduction in T cells, in combination with a potentiating agent, such as cyclophosphamide, to produce potent T cell mediated responses, are described. Compositions comprising the PD-1 antagonists and potentiating agents useful in the methods of the invention are also disclosed.

L'invention concerne des méthodes de traitement du cancer et des maladies infectieuses au moyen d'un schéma thérapeutique consistant à administrer un composé destiné à réduire la transduction de signal inhibiteur dans les lymphocytes T, associé à un agent de potentialisation, tel que la cyclophosphamide, pour produire des réponses puissantes induites par les lymphocytes T. L'invention concerne également des compositions contenant lesdits antagonistes de PD-1 et agents de potentialisation, utiles dans les méthodes selon l'invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions of pd-1 antagonists and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions of pd-1 antagonists and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of pd-1 antagonists and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1732764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.